Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qi Pauls

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Prehospital Emergency Care|May 11, 2017
Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT IIIKurt R Denninghoff, Tomas Nuño, Qi Pauls, et al.
Neurology|April 16, 2024
Glucose Control and Risk of Symptomatic Intracerebral Hemorrhage Following Thrombolysis for Acute Ischemic Stroke: A SHINE Trial AnalysisAndrew M Southerland, Stephan A Mayer, Nicole A Chiota-McCollum, et al.
JAMA|July 24, 2019
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical TrialKaren C Johnston, Askiel Bruno, Qi Pauls, et al.
Critical Care Medicine|February 8, 2019
The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury: Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical TrialLisa H Merck, Sharon D Yeatts, Robert Silbergleit, et al.
Journal of Neurotrauma|December 15, 2020
Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III TrialFrederick Korley, Qi Pauls, Sharon D Yeatts, et al.
Journal of Neurotrauma|February 23, 2019
Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT IIIMichael Frankel, Liqiong Fan, Sharon D Yeatts, et al.
Journal of the American Heart Association|August 23, 2025
Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA-Cognition StudyRonald M Lazar, George Howard, Michael T Brewer, et al.
Annals of Neurology|February 25, 2026
Apixaban Versus Aspirin and Risk of Hemorrhage in the ARCADIA TrialHooman Kamel, W T Longstreth, David L Tirschwell, et al.
Endoscopy|July 14, 2015
Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled studyMohammad Yaghoobi, Qi Pauls, Valerie Durkalski, et al.
Journal of the American Heart Association|July 29, 2025
Heart Rhythm Monitoring Practices, Detection of Atrial Fibrillation, and Effect of Anticoagulation in the ARCADIA TrialHooman Kamel, Mitchell S V Elkind, Richard A Kronmal, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Prehospital Emergency Care|May 11, 2017
Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT IIIKurt R Denninghoff, Tomas Nuño, Qi Pauls, et al.
Neurology|April 16, 2024
Glucose Control and Risk of Symptomatic Intracerebral Hemorrhage Following Thrombolysis for Acute Ischemic Stroke: A SHINE Trial AnalysisAndrew M Southerland, Stephan A Mayer, Nicole A Chiota-McCollum, et al.
JAMA|July 24, 2019
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical TrialKaren C Johnston, Askiel Bruno, Qi Pauls, et al.
Critical Care Medicine|February 8, 2019
The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury: Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical TrialLisa H Merck, Sharon D Yeatts, Robert Silbergleit, et al.
Journal of Neurotrauma|December 15, 2020
Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III TrialFrederick Korley, Qi Pauls, Sharon D Yeatts, et al.
Journal of Neurotrauma|February 23, 2019
Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT IIIMichael Frankel, Liqiong Fan, Sharon D Yeatts, et al.
Journal of the American Heart Association|August 23, 2025
Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA-Cognition StudyRonald M Lazar, George Howard, Michael T Brewer, et al.
Annals of Neurology|February 25, 2026
Apixaban Versus Aspirin and Risk of Hemorrhage in the ARCADIA TrialHooman Kamel, W T Longstreth, David L Tirschwell, et al.
Endoscopy|July 14, 2015
Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled studyMohammad Yaghoobi, Qi Pauls, Valerie Durkalski, et al.
Journal of the American Heart Association|July 29, 2025
Heart Rhythm Monitoring Practices, Detection of Atrial Fibrillation, and Effect of Anticoagulation in the ARCADIA TrialHooman Kamel, Mitchell S V Elkind, Richard A Kronmal, et al.
Pageof 3